Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.82 USD | -3.42% |
|
-0.35% | +12.80% |
06-18 | OncoCyte Names Andrea James Chief Financial Officer | MT |
06-17 | OncoCyte Corporation Appoints Andrea James as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.80% | 39.02M | |
-41.45% | 8.21B | |
+8.13% | 3.55B | |
-1.66% | 2.24B | |
-27.06% | 1.86B | |
-21.85% | 1.68B | |
+12.60% | 940M | |
+22.50% | 751M | |
-12.66% | 667M | |
+1.19% | 286M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q2 Revenue $463,000, vs. Street Est of $0.35M